RetractedArticleJournal of Cancer2022

HER4 Promotes Osteosarcoma Progression and Predicts Poor Prognosis through the PTEN-PI3K/AKT Pathway.

Kun Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.